{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/AIM/CLBX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CELLBXHEALTH PLC (AIM: CLBX) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is CELLBXHEALTH PLC, listed on AIM under ticker CLBX, with ISIN GB0034330679 and LEI 213800BY11K6W3NMS374. Its security type is Corporate, its segment is ASX1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 48 filings across 36 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The latest filing is dated 2026-10-21, a financial statement, 16 days before the record date of 2026-11-06. The AIM median cadence gap is 7.0 days across 594 issuers, and the AIM median latency is 4 days. The sector median cadence gap is 6.0 days across 51 issuers, and the sector median latency is 4.0 days.\n\n## Auditor\n\nThe auditor of record is MHA, and its location is not on the record. Auditor changes are not on the record, as the market's record does not yet carry a lifecycle type map for this register.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the market's index does not yet carry a lifecycle type map for this register. The halt flag is listed, not halted.\n\n## Orderability\n\nUnder rule version acm-68000/uk/product-governance-fca-prod-sourcebook/r1, as of chapter date 2026-11-04, the signal ACM-200 is determinable for elective professional client and for eligible counterparty.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page, count 0.\n\n## Open research\n\nNo openly published research notes were found, count 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The issuer has no sealed years, and the market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CLBX (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/04985171 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/CLBX/cellbxhealth-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/CLBX (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://find-and-update.company-information.service.gov.uk/company/04985171/filing-history/MzUzMTY3MTgzNmFkaXF6a2N4/document?format=pdf&download=0 (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.uk-cm-kg.ai/record/AIM/CLBX (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "read by ChatGPT (batch)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/04985171/filing-history/MzUzMTY3MTgzNmFkaXF6a2N4/document?format=pdf&download=0",
    "state": "filled",
    "value": "MHA"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/AIM/CLBX",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 594,
     "median_cadence_gap_days": 7,
     "median_filings": 33.5,
     "median_latency_days": 4,
     "name": "AIM"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 3,
    "ch_accounts_filed": 1,
    "ch_capital": 3,
    "ch_confirmation_statement": 1,
    "ch_officer_change": 9,
    "ch_other": 1,
    "ch_resolution": 2,
    "corporate_action": 3,
    "director_dealing": 2,
    "early_warning": 1,
    "financial_statement": 6,
    "regulatory_announcement": 16
   },
   "cadence_median_gap_days": 6,
   "filing_days": 36,
   "filings": 48,
   "latency_days": 16,
   "latest": [
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.investegate.co.uk/announcement/rns/cellbxhealth-plc--clbx/q3-trading-update-and-fy-2026-outlook/9832820",
     "title": "Q3 Trading Update and FY 2026 Outlook",
     "type": "financial_statement"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.investegate.co.uk/announcement/rns/cellbxhealth-plc--clbx/master-services-agreement-with-swiss-biotech-co-/9832819",
     "title": "Master Services Agreement with Swiss biotech co",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-14",
     "source": "https://www.investegate.co.uk/announcement/rns/cellbxhealth-plc--clbx/new-statement-of-work-with-us-based-pharma-company/9821364",
     "title": "New Statement of Work with US-Based Pharma Company",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-08-11",
     "source": "https://www.investegate.co.uk/announcement/rns/cellbxhealth-plc--clbx/parsortix-ctcs-used-for-brain-cancer-detection/9714385",
     "title": "Parsortix CTCs used for Brain Cancer detection",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-08-03",
     "source": "https://www.investegate.co.uk/announcement/rns/cellbxhealth-plc--clbx/parsortix-ctcs-used-for-adc-target-assessment/9699754",
     "title": "Parsortix CTCs used for ADC target assessment",
     "type": "regulatory_announcement"
    }
   ],
   "latest_filing_date": "2026-10-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/CLBX",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "AIM"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CLBX",
    "state": "confirmed",
    "value": "GB0034330679"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/04985171",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB0034330679)",
    "state": "sourced",
    "value": "213800BY11K6W3NMS374"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "CELLBXHEALTH PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/CLBX/cellbxhealth-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "ASX1"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "CLBX"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/CLBX/cellbxhealth-plc/company-page",
    "state": "sourced",
    "value": "https://cellbxhealth.com/"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:e1e0803d1c5dbc08f42518e1dfad061ea4515274aba772de80c89e861bdc8c3b",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/AIM/CLBX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:e1e0803d1c5dbc08f42518e1dfad061ea4515274aba772de80c89e861bdc8c3b",
 "path": "/uk/AIM/CLBX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is CELLBXHEALTH PLC, listed on AIM under ticker CLBX, with ISIN GB0034330679 and LEI 213800BY11K6W3NMS374. Its security type is Corporate, its segment is ASX1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 48 filings across 36 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The latest filing is dated 2026-10-21, a financial statement, 16 days before the record date of 2026-11-06. The AIM median cadence gap is 7.0 days across 594 issuers, and the AIM median latency is 4 days. The sector median cadence gap is 6.0 days across 51 issuers, and the sector median latency is 4.0 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is MHA, and its location is not on the record. Auditor changes are not on the record, as the market's record does not yet carry a lifecycle type map for this register.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the market's index does not yet carry a lifecycle type map for this register. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under rule version acm-68000/uk/product-governance-fca-prod-sourcebook/r1, as of chapter date 2026-11-04, the signal ACM-200 is determinable for elective professional client and for eligible counterparty.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page, count 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found, count 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. The issuer has no sealed years, and the market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CLBX"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/04985171"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/CLBX/cellbxhealth-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/CLBX"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://find-and-update.company-information.service.gov.uk/company/04985171/filing-history/MzUzMTY3MTgzNmFkaXF6a2N4/document?format=pdf&download=0"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/AIM/CLBX"
  }
 ],
 "title": "CELLBXHEALTH PLC (CLBX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}